Clinical Trials Browser

Phase 1 × Withdrawn × dabrafenib × Clear all

NCT02447939 2018-09-14

Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma

Phase 1 Withdrawn

Melanoma

NCT02915666 2018-05-15

A Clinical Trial of Patients With Melanoma

Phase 1 Withdrawn

Melanoma

NCT02357732 2015-12-11

Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib

Phase 1 Withdrawn

Melanoma